Ascendis Pharma(ASND)
$267.07+7.79 (+3.00%)
ASND
Ascendis Pharma earnings date
$267.07
At close:+7.79 (+3.00%)
Want to see ASND full AI Analyst Report?
Ascendis Pharma (ASND) Q4 2023 Earnings Report
790 Followers
ASND Q4 2023 EPS Results
- Actual EPS
- -$1.70
- Consensus EPS
- -$2.01
- Beat/Miss
- Beat by +$0.30
- One Year Ago EPS
- -$4.09
ASND Q4 2023 Revenue Results
- Actual Revenue
- $148.05M
- Expected Revenue
- $103.38M
- Beat/Miss
- Beat by +$44.67M
- YoY Revenue Growth
- +534.32%
Earnings Announcement Details
- Quarter
- Q4 2023
- Date
- 02/07/2024
- Time
- After Close
- Conference Call
- Wednesday, February 7, 2024
ASND Upcoming Earnings
Ascendis Pharma's next earnings date is estimated for February 17, 2027, based on past reporting schedules.
Q4 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
ASND Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 17, 2027 | 2026 (Q4) | 1.75- | -0.61 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | 0.871.19 | -1.11 | 208.00% (+2.30) | |
| Aug 13, 2026 | 2026 (Q2) | 1.663.13 | -0.91 | 445.12% (+4.04) | |
| May 07, 2026 | 2026 (Q1) | ―10.79 | -1.75 | 717.09% (+12.53) | |
| Feb 11, 2026 | 2025 (Q4) | -0.09-0.61 | -0.71 | 14.06% (+0.10) | |
| Nov 12, 2025 | 2025 (Q3) | -0.27-1.11 | -1.9 | 41.86% (+0.80) | |
| Aug 07, 2025 | 2025 (Q2) | -1.42-0.91 | -2.11 | 57.07% (+1.21) | |
| May 01, 2025 | 2025 (Q1) | -1.62-1.75 | -2.54 | 31.30% (+0.80) | |
| Feb 12, 2025 | 2024 (Q4) | -1.09-0.71 | -1.7 | 58.44% (+1.00) | |
| Nov 14, 2024 | 2024 (Q3) | -1.73-1.90 | -2.98 | 36.06% (+1.07) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
